Isolation, Identification and Structural Verification of a Methylene-Bridged Naloxone “Dimer” Formed by Formaldehyde
- 20 November 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 111 (6), 1682-1689
- https://doi.org/10.1016/j.xphs.2021.11.014
Abstract
No abstract availableFunding Information
- Hexal AG
This publication has 27 references indexed in Scilit:
- Buprenorphine/NaloxoneDrugs, 2009
- Solubility Challenge: Can You Predict Solubilities of 32 Molecules Using a Database of 100 Reliable Measurements?Journal of Chemical Information and Modeling, 2008
- Simultaneous determination of formic acid and formaldehyde in pharmaceutical excipients using headspace GC/MSJournal of Pharmaceutical and Biomedical Analysis, 2006
- Influence of Formaldehyde Impurity in Polysorbate 80 and PEG?300 on the Stability of a Parenteral Formulation of BMS?204352: Identification and Control of the Degradation ProductPharmaceutical Development and Technology, 2004
- Office-Based Treatment of Opiate Addiction with a Sublingual-Tablet Formulation of Buprenorphine and NaloxoneThe New England Journal of Medicine, 2003
- The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinicDrug and Alcohol Dependence, 2003
- Aspects of Melatonin Manufacturing and Requirements for a Reliable Active ComponentNeurosignals, 1999
- An analytical study of the interaction of low levels of formaldehyde with active pharmaceuticalsJournal of Pharmacy and Pharmacology, 1998
- Structural Characterization of Contaminants Found in Commercial Preparations of Melatonin: Similarities to Case-Related Compounds from l-Tryptophan Associated with Eosinophilia-Myalgia SyndromeChemical Research in Toxicology, 1998
- Pharmaceutical application of LC-MS. 1 — Characterization of a famotidine degradates in a package screening study by LC-APCI MSJournal of Pharmaceutical and Biomedical Analysis, 1994